EPCLUSA
EPCLUSA
Approved
DIN Number
02456370
Drug Class
Human
Market Date
Aug 2, 2016
Company
HC
gilead sciences canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02456370
AIG Number0258270001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AP55 SOFOSBUVIR AND VELPATASVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.40.24
Health Canada Classification
ACTIVE INGREDIENTS (2)
SOFOSBUVIRActive
Strength: 400 MG
Monograph: SOFOSBUVIR
VELPATASVIRActive
Strength: 100 MG
Monograph: VELPATASVIR